| Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential |
48 |
| Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm |
43 |
| Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy |
37 |
| Isocitrate dehydrogenase inhibitors in acute myeloid leukemia |
17 |
| Novel insights into MSC-EVs therapy for immune diseases |
14 |
| Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia |
14 |
| Epigenetic heterogeneity in cancer |
13 |
| Mesothelin as a biomarker for targeted therapy |
12 |
| Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer |
10 |
| Molecular landscape and targeted therapy of acute myeloid leukemia |
10 |
| Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia |
9 |
| microRNA based prognostic biomarkers in pancreatic Cancer |
8 |
| The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients |
8 |
| Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma |
7 |
| Platelet protein biomarker panel for ovarian cancer diagnosis |
7 |
| SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis |
6 |
| NKX2. PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors |
5 |
| Targeted therapies for myeloproliferative neoplasms |
5 |
| PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge |
5 |
| Phosphatidylinositol 3-kinase-delta (PI3K-delta) is a potential therapeutic target in adult T-cell leukemia-lymphoma |
5 |
| Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia |
5 |
| Longitudinal study of leukocyte DNA methylation and biomarkers for cancer risk in older adults |
5 |
| Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma |
5 |
| Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1 |
4 |
| Reduced nuclear DNA methylation and mitochondrial transcript changes in adenomas do not associate with mtDNA methylation |
4 |
| EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies |
4 |
| Evaluation of breast stiffness measured by ultrasound and breast density measured by MRI using a prone-supine deformation model |
3 |
| Protein kinase inhibitors for acute leukemia |
3 |
| SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms |
3 |
| Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour |
3 |
| Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers |
3 |
| Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose |
3 |
| Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort |
3 |
| Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL |
3 |
| Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutation |
2 |
| Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? |
2 |
| Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts |
2 |
| Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study |
2 |
| The association between early neurological deterioration and whole blood purine concentration during acute stroke |
2 |
| Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer |
2 |
| Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development |
2 |
| Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status: a case control study |
2 |
| Acute myeloid leukemia in a father and son with a germline mutation of ASXL1 |
2 |
| Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice |
2 |
| Cyclin D1+large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge |
2 |
| The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo |
2 |
| Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma |
1 |
| Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy |
1 |
| Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |
1 |
| Aptamer-based search for correlates of plasma and serum water T-2: implications for early metabolic dysregulation and metabolic syndrome |
1 |
